ArticleMolecular medicine reports2018
Shikonin sensitizes wild‑type EGFR NSCLC cells to erlotinib and gefitinib therapy.
Yang-Ling Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ArticleMolecular medicine reports2018
Yang-Ling Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.